New registry aims to unlock head and neck cancer secrets in asian patients
NCT ID NCT02546895
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study gathered medical information and tissue samples from 2,000 head and neck cancer patients in South Korea. The goal was to learn more about how the disease behaves in Asian populations, since most existing research comes from Western countries. By analyzing this data, researchers hope to find better ways to predict treatment outcomes and side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
2,000 people
The number who actually took part.
- Started
-
Sep 2015
- Finished
-
Dec 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Pathologically proven head and neck cancer patients, who are referred to Samsung Medical Center
- Ages
-
19 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adults over 19 years-old * Patients diagnosed as head and neck cancer histopathologically according to American Joint Committee on Cancer, Cancer staging manual, 7th edition at Samsung Medical Center: * Comprise a part of head and neck * Oral cavity * Pharynx * Larynx * Hypopharynx * Nasal cavity * Paranasal sinus * Nasopharynx * Salivary gland * Skin in the head and neck * In case patients are diagnosed at other hospitals, it can be possible to register the tissue of cancer cell with Samsung medical center and confirm the diagnosis by pathologists of Samsung medical center. * Histopathological type: * Squamous cell carcinoma * Malignant melanoma * Sarcoma and other carcinomas are included. * Metastasis of Unknown Origin (MUO) at head and neck is included. * Patients who receive a proper treatment as scheduled. * Informed consents: patients who understand the purpose of study and are capable of giving a written consent. Exclusion criteria: * Patients who do not meet the requirements of inclusion criteria
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Head and neck cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Samsung Medical Center
Seoul, 135-710, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a dental assistant keep cancer Patients' mouths healthier during radiation?
- Why do Non-Smokers get head and neck cancer? scientists probe tumor DNA
- Re-irradiation plus cetuximab targets head and neck tumors that return
- Sharper tumor maps: PET scans could tighten radiation beams
- Five days of radiation instead of weeks: a new test for head and neck cancer
- Can an online program ease the burden on cancer caregivers?